logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Select committee join Ofsted posse in sponsor inspection standoff

7 November 2013

The Education Select Committee have weighed into the ongoing debate between the DfE and Ofsted on whether organisations which sponsor academies should be inspected.

Whilst Ofsted currently have the power to inspect the schools within an academy chain, there is no power to inspect the sponsor itself. The power to appoint and regulate academy sponsors is with the DfE.

The Committee have stated that Ofsted’s powers should be extended to sponsors, echoing Ofsted chief, Sir Michael Wilshaw’s view, that there “needs to be a level playing field in the accountability of organisations running groups of schools”. This is at odds with the DfE’s standpoint which is that it alone should examine the performance of chains.

It will be interesting so see whether the Committee’s intervention will put pressure on the DfE to accede to Ofsted’s wishes and put an end to the current standoff.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up